vimarsana.com

Page 241 - Advanced Cellular Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Teva, Glenmark To Pay $255M, Divest Cholesterol Drug to Settle DOJ Price Fixing Charges

Generic drugmakers Teva and Glenmark recently became the sixth and seventh drugmakers to resolve criminal charges as a result of the DOJ’s yearslong investigation into generic drug price fixing. The settlement agreement requires both companies to pay hefty fines as well as divest their drug lines for pravastatin, a widely used statin that lowers cholesterol.

Here s Why Many Americans Are Unable to Afford Their Drugs

Pharmaceutical manufacturers say high U.S. prices support research and development and point out that Americans tend to get new treatments first. But recent research has shown that the price of a drug is related neither to the amount of research and development required to bring it to market nor its therapeutic value.

A More Predictive and Preventive Cardiothoracic Imaging Interpretation Model to Avoid Delayed Diagnoses

The current imaging interpretation model undoubtedly has reached its breaking point due to increasing volumes and fewer radiologists. The time is now to solve this systemic imaging interpretation issue.

Corporate Head of Benefits – The Most Powerful Position in Healthcare for 60% of Americans

Employer-sponsored health insurance now costs approximately $12,000 per plan member per year. Accordingly, for many employers, healthcare and health insurance are the second largest company expense after payroll. The Head of Benefits is in charge of this expense and is in the best position to use it for positive change.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.